The mutation-free embryo for in vitro fertilization selected by MALBAC-PGD resulted in a healthy live birth from a family carrying PKD 1 mutation
Journal of Assisted Reproduction and Genetics Aug 25, 2017
Li W, et al. – This study is conducted to report a new strategy of performing preimplantation genetic diagnosis (PGD) in screening (target–) mutation–free embryos. The first multiple annealing and looping–based amplification cycles (MALBAC)–PGD attempt in autosomal dominant polycystic kidney disease (ADPKD) patient resulted in a healthy live birth free of ADPKD and chromosomal anomalies. MALBAC–PGD also enables selecting embryos without aneuploidy together and target gene mutation, thereby increasing implantation and live birth rates.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries